| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 166 | 2023 | 8861 | 5.450 |
Why?
|
| Glioma | 81 | 2021 | 3401 | 4.460 |
Why?
|
| Central Nervous System Neoplasms | 26 | 2021 | 895 | 4.370 |
Why?
|
| Oligodendroglioma | 48 | 2017 | 279 | 4.280 |
Why?
|
| Astrocytoma | 59 | 2020 | 790 | 4.170 |
Why?
|
| Glioblastoma | 72 | 2019 | 3481 | 2.920 |
Why?
|
| Chromosomes, Human, Pair 19 | 35 | 2016 | 367 | 2.660 |
Why?
|
| World Health Organization | 17 | 2021 | 1318 | 2.080 |
Why?
|
| Isocitrate Dehydrogenase | 20 | 2020 | 871 | 2.020 |
Why?
|
| Pathology, Clinical | 6 | 2015 | 368 | 1.760 |
Why?
|
| Terminology as Topic | 5 | 2020 | 1547 | 1.470 |
Why?
|
| Genes, Tumor Suppressor | 24 | 2010 | 1097 | 1.430 |
Why?
|
| Dacarbazine | 11 | 2017 | 566 | 1.340 |
Why?
|
| Chromosomes, Human, Pair 1 | 26 | 2016 | 658 | 1.290 |
Why?
|
| Nervous System Neoplasms | 10 | 2014 | 91 | 1.230 |
Why?
|
| Meningioma | 16 | 2017 | 1209 | 1.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 22 | 2018 | 705 | 1.150 |
Why?
|
| Mutation | 73 | 2020 | 29786 | 1.120 |
Why?
|
| Loss of Heterozygosity | 24 | 2009 | 684 | 1.100 |
Why?
|
| Gene Deletion | 30 | 2012 | 2751 | 1.050 |
Why?
|
| Chromosome Deletion | 22 | 2016 | 1401 | 1.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 10 | 2019 | 2043 | 1.020 |
Why?
|
| Pathology | 2 | 2019 | 272 | 0.990 |
Why?
|
| Antineoplastic Agents, Alkylating | 9 | 2017 | 627 | 0.990 |
Why?
|
| Meningeal Neoplasms | 12 | 2018 | 1241 | 0.970 |
Why?
|
| Immunohistochemistry | 56 | 2018 | 11366 | 0.940 |
Why?
|
| Genes, Neurofibromatosis 2 | 12 | 2003 | 124 | 0.870 |
Why?
|
| Tumor Suppressor Protein p53 | 21 | 2013 | 2949 | 0.850 |
Why?
|
| Molecular Biology | 9 | 2013 | 596 | 0.820 |
Why?
|
| Genes, p53 | 23 | 2005 | 755 | 0.820 |
Why?
|
| Neurocytoma | 4 | 2004 | 30 | 0.740 |
Why?
|
| Ependymoma | 4 | 2020 | 334 | 0.720 |
Why?
|
| Proto-Oncogene Proteins | 15 | 2019 | 4554 | 0.720 |
Why?
|
| Tumor Suppressor Proteins | 20 | 2017 | 2850 | 0.690 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2017 | 170 | 0.680 |
Why?
|
| Pathology, Molecular | 4 | 2021 | 326 | 0.680 |
Why?
|
| Pituitary Neoplasms | 5 | 2018 | 1345 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2019 | 78 | 0.670 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 20 | 2005 | 335 | 0.660 |
Why?
|
| Chromosomes, Human, Pair 10 | 9 | 2009 | 287 | 0.660 |
Why?
|
| Paraffin Embedding | 4 | 2010 | 299 | 0.660 |
Why?
|
| DNA, Neoplasm | 22 | 2009 | 1758 | 0.630 |
Why?
|
| Humans | 346 | 2023 | 744366 | 0.620 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2008 | 85 | 0.620 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 250 | 0.610 |
Why?
|
| Brain | 27 | 2023 | 26388 | 0.600 |
Why?
|
| Ki-67 Antigen | 8 | 2018 | 644 | 0.590 |
Why?
|
| Chromosome Mapping | 22 | 2001 | 4740 | 0.580 |
Why?
|
| In Situ Hybridization, Fluorescence | 17 | 2012 | 2649 | 0.560 |
Why?
|
| Spinal Cord Neoplasms | 6 | 2014 | 281 | 0.560 |
Why?
|
| Polymerase Chain Reaction | 30 | 2015 | 6171 | 0.550 |
Why?
|
| Genes, Retinoblastoma | 7 | 2001 | 136 | 0.540 |
Why?
|
| Central Nervous System | 5 | 2021 | 1357 | 0.520 |
Why?
|
| Frontal Lobe | 2 | 2016 | 1406 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 22 | 6 | 2003 | 351 | 0.510 |
Why?
|
| DNA-Binding Proteins | 17 | 2015 | 9647 | 0.500 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2011 | 496 | 0.480 |
Why?
|
| Telepathology | 2 | 2012 | 76 | 0.480 |
Why?
|
| Gliosis | 4 | 2011 | 245 | 0.470 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2014 | 45 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 18 | 2019 | 9240 | 0.470 |
Why?
|
| Point Mutation | 6 | 2016 | 1624 | 0.460 |
Why?
|
| Oligodendroglia | 6 | 2018 | 517 | 0.440 |
Why?
|
| Gene Amplification | 13 | 2011 | 1063 | 0.440 |
Why?
|
| Computational Biology | 2 | 2015 | 3519 | 0.430 |
Why?
|
| Hemangiopericytoma | 3 | 2018 | 77 | 0.420 |
Why?
|
| Agglutinins | 2 | 2002 | 29 | 0.420 |
Why?
|
| Base Sequence | 34 | 2014 | 12797 | 0.410 |
Why?
|
| Astrocytes | 12 | 2013 | 1273 | 0.410 |
Why?
|
| Pathology Department, Hospital | 1 | 2011 | 10 | 0.410 |
Why?
|
| Molecular Diagnostic Techniques | 4 | 2015 | 602 | 0.410 |
Why?
|
| Formaldehyde | 2 | 2010 | 353 | 0.400 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2010 | 126 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2011 | 322 | 0.390 |
Why?
|
| Neurofibromatosis 2 | 6 | 2004 | 380 | 0.380 |
Why?
|
| Fixatives | 1 | 2010 | 94 | 0.380 |
Why?
|
| Encephalocele | 2 | 2023 | 136 | 0.380 |
Why?
|
| DNA Repair Enzymes | 6 | 2016 | 349 | 0.380 |
Why?
|
| Neoplastic Stem Cells | 8 | 2017 | 1376 | 0.360 |
Why?
|
| Carrier Proteins | 9 | 2000 | 5023 | 0.360 |
Why?
|
| Fires | 1 | 2011 | 173 | 0.350 |
Why?
|
| Schools, Medical | 1 | 2016 | 881 | 0.340 |
Why?
|
| Trans-Activators | 1 | 2019 | 2926 | 0.330 |
Why?
|
| Diagnosis, Differential | 24 | 2016 | 12961 | 0.330 |
Why?
|
| DNA Mutational Analysis | 19 | 2014 | 4185 | 0.330 |
Why?
|
| DNA Modification Methylases | 4 | 2016 | 206 | 0.330 |
Why?
|
| Polymorphism, Genetic | 12 | 2002 | 4328 | 0.320 |
Why?
|
| Molecular Sequence Data | 34 | 2014 | 18111 | 0.310 |
Why?
|
| Phosphoric Monoester Hydrolases | 5 | 2004 | 431 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 1998 | 535 | 0.310 |
Why?
|
| Faculty, Medical | 1 | 2016 | 1181 | 0.310 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2007 | 365 | 0.300 |
Why?
|
| Neurilemmoma | 4 | 2003 | 547 | 0.300 |
Why?
|
| Proteins | 13 | 2010 | 6100 | 0.300 |
Why?
|
| Cranial Nerve Neoplasms | 3 | 1997 | 129 | 0.300 |
Why?
|
| Genes, p16 | 6 | 2005 | 157 | 0.300 |
Why?
|
| Genes, erbB-1 | 6 | 2006 | 161 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 17 | 8 | 1998 | 437 | 0.300 |
Why?
|
| Hospitals, General | 1 | 2011 | 749 | 0.290 |
Why?
|
| Repressor Proteins | 7 | 2018 | 3024 | 0.290 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 1999 | 134 | 0.270 |
Why?
|
| Middle Aged | 99 | 2020 | 213390 | 0.270 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 205 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2013 | 2504 | 0.270 |
Why?
|
| Fatal Outcome | 7 | 2014 | 1851 | 0.270 |
Why?
|
| History, 20th Century | 4 | 2019 | 2740 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2012 | 8949 | 0.260 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 182 | 0.260 |
Why?
|
| Male | 121 | 2021 | 350115 | 0.260 |
Why?
|
| DNA Methylation | 7 | 2019 | 4285 | 0.260 |
Why?
|
| Adult | 96 | 2020 | 214052 | 0.260 |
Why?
|
| Prognosis | 36 | 2023 | 29060 | 0.250 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 2938 | 0.250 |
Why?
|
| Research Design | 3 | 2019 | 5984 | 0.250 |
Why?
|
| Neoplasm Proteins | 11 | 2018 | 3707 | 0.250 |
Why?
|
| Receptors, Growth Factor | 1 | 2005 | 334 | 0.250 |
Why?
|
| Gene Expression Profiling | 15 | 2021 | 9445 | 0.250 |
Why?
|
| Simplexvirus | 6 | 2011 | 803 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2018 | 8432 | 0.240 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 553 | 0.240 |
Why?
|
| Occupational Health | 1 | 2011 | 808 | 0.240 |
Why?
|
| Cerebral Ventricle Neoplasms | 2 | 2018 | 44 | 0.240 |
Why?
|
| Procarbazine | 5 | 2011 | 181 | 0.240 |
Why?
|
| Lomustine | 5 | 2011 | 59 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2008 | 1434 | 0.240 |
Why?
|
| Education, Medical | 1 | 2016 | 1722 | 0.240 |
Why?
|
| Peripheral Nervous System Neoplasms | 3 | 2002 | 122 | 0.240 |
Why?
|
| Female | 123 | 2020 | 380193 | 0.230 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2005 | 143 | 0.230 |
Why?
|
| Ganglioglioma | 3 | 2011 | 42 | 0.230 |
Why?
|
| Single-Cell Analysis | 7 | 2021 | 2182 | 0.230 |
Why?
|
| Hospitals | 2 | 2020 | 3954 | 0.230 |
Why?
|
| Pigmentation | 1 | 2004 | 148 | 0.230 |
Why?
|
| Chromosome Aberrations | 8 | 2009 | 1813 | 0.220 |
Why?
|
| Gene Dosage | 8 | 2011 | 1252 | 0.220 |
Why?
|
| Neurofibroma | 2 | 2001 | 106 | 0.220 |
Why?
|
| Cyclin-Dependent Kinases | 7 | 2004 | 671 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 12 | 2015 | 11525 | 0.220 |
Why?
|
| DNA Copy Number Variations | 3 | 2016 | 1941 | 0.210 |
Why?
|
| Alleles | 20 | 2004 | 6933 | 0.210 |
Why?
|
| Gene Silencing | 2 | 2014 | 1539 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 14 | 2013 | 6313 | 0.210 |
Why?
|
| Sequence Analysis, RNA | 5 | 2018 | 2012 | 0.210 |
Why?
|
| Cell Lineage | 5 | 2019 | 2504 | 0.210 |
Why?
|
| Exons | 12 | 2011 | 2439 | 0.210 |
Why?
|
| Glial Fibrillary Acidic Protein | 6 | 2006 | 529 | 0.210 |
Why?
|
| Medulloblastoma | 5 | 2002 | 683 | 0.210 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 6 | 2014 | 1115 | 0.210 |
Why?
|
| Craniopharyngioma | 2 | 2015 | 281 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2016 | 2943 | 0.200 |
Why?
|
| Vincristine | 5 | 2011 | 1039 | 0.200 |
Why?
|
| Germinoma | 1 | 2002 | 134 | 0.200 |
Why?
|
| History, 19th Century | 2 | 2016 | 720 | 0.200 |
Why?
|
| Phospholipases A | 1 | 2002 | 216 | 0.200 |
Why?
|
| Meninges | 1 | 2023 | 190 | 0.200 |
Why?
|
| Nuclear Proteins | 8 | 2006 | 5856 | 0.190 |
Why?
|
| Integrins | 1 | 2005 | 846 | 0.190 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 82 | 0.190 |
Why?
|
| Lymphoma, B-Cell | 5 | 2000 | 931 | 0.190 |
Why?
|
| Homozygote | 9 | 2002 | 1787 | 0.190 |
Why?
|
| Protein Subunits | 1 | 2004 | 959 | 0.190 |
Why?
|
| Quinazolines | 5 | 2010 | 1356 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2002 | 462 | 0.190 |
Why?
|
| Ependyma | 1 | 2020 | 54 | 0.190 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 4 | 2018 | 378 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2015 | 5172 | 0.180 |
Why?
|
| Craniotomy | 5 | 2015 | 729 | 0.180 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 3508 | 0.180 |
Why?
|
| Anaplasia | 1 | 1999 | 16 | 0.180 |
Why?
|
| Cerebellar Neoplasms | 4 | 2014 | 587 | 0.180 |
Why?
|
| Genetic Techniques | 2 | 2008 | 435 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2019 | 1534 | 0.180 |
Why?
|
| Brain Stem | 3 | 1994 | 846 | 0.170 |
Why?
|
| Telomerase | 4 | 2018 | 730 | 0.170 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 890 | 0.170 |
Why?
|
| Membrane Proteins | 10 | 2010 | 7882 | 0.170 |
Why?
|
| Aged | 63 | 2019 | 163288 | 0.170 |
Why?
|
| Retinoblastoma Protein | 3 | 2002 | 705 | 0.170 |
Why?
|
| Teratoma | 1 | 2002 | 395 | 0.170 |
Why?
|
| Neurofibromatoses | 1 | 2003 | 299 | 0.170 |
Why?
|
| Mutation, Missense | 8 | 2018 | 2566 | 0.170 |
Why?
|
| Cell Line, Tumor | 15 | 2019 | 16690 | 0.170 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2003 | 604 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 28 | 2016 | 35425 | 0.170 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 1622 | 0.170 |
Why?
|
| Supratentorial Neoplasms | 1 | 2020 | 160 | 0.170 |
Why?
|
| Disease Progression | 15 | 2017 | 13286 | 0.170 |
Why?
|
| Nucleolus Organizer Region | 3 | 1993 | 26 | 0.170 |
Why?
|
| RNA, Messenger | 8 | 2014 | 13035 | 0.170 |
Why?
|
| Genetic Markers | 12 | 2005 | 2634 | 0.170 |
Why?
|
| Neurofibromatosis 1 | 4 | 2004 | 570 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 6 | 2014 | 4463 | 0.160 |
Why?
|
| Genetic Vectors | 10 | 2011 | 3424 | 0.160 |
Why?
|
| Cyclins | 3 | 2000 | 603 | 0.160 |
Why?
|
| Health Promotion | 1 | 2011 | 2205 | 0.160 |
Why?
|
| X Chromosome | 1 | 2002 | 814 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2009 | 2576 | 0.160 |
Why?
|
| Combined Modality Therapy | 13 | 2016 | 8642 | 0.160 |
Why?
|
| Biopsy | 7 | 2016 | 6755 | 0.160 |
Why?
|
| Histiocytosis | 1 | 2018 | 40 | 0.160 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1999 | 211 | 0.160 |
Why?
|
| Histones | 3 | 2018 | 2598 | 0.160 |
Why?
|
| Muscle Proteins | 3 | 2008 | 1158 | 0.160 |
Why?
|
| Genes, Neurofibromatosis 1 | 3 | 2001 | 79 | 0.160 |
Why?
|
| Medical Informatics | 2 | 2016 | 745 | 0.160 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2018 | 173 | 0.160 |
Why?
|
| Endometrium | 1 | 2001 | 424 | 0.160 |
Why?
|
| Receptors, Cell Surface | 3 | 2021 | 2865 | 0.160 |
Why?
|
| Scalp | 1 | 2021 | 380 | 0.160 |
Why?
|
| Microsatellite Repeats | 8 | 2004 | 802 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2014 | 934 | 0.150 |
Why?
|
| Protein Kinase C-alpha | 1 | 2018 | 112 | 0.150 |
Why?
|
| Spinal Cord | 3 | 2016 | 1810 | 0.150 |
Why?
|
| Signal Transduction | 12 | 2015 | 23404 | 0.150 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 1999 | 224 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 7 | 2017 | 4805 | 0.150 |
Why?
|
| Genome | 1 | 2006 | 1807 | 0.150 |
Why?
|
| Vestibular Nerve | 1 | 1997 | 101 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 1998 | 473 | 0.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2002 | 798 | 0.150 |
Why?
|
| Third Ventricle | 1 | 2018 | 76 | 0.150 |
Why?
|
| Angiomatosis | 1 | 1997 | 49 | 0.150 |
Why?
|
| Blotting, Western | 8 | 2009 | 5181 | 0.150 |
Why?
|
| Epithelium | 2 | 2001 | 1679 | 0.140 |
Why?
|
| Neurofibromin 2 | 8 | 2013 | 267 | 0.140 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 277 | 0.140 |
Why?
|
| Tight Junctions | 2 | 2010 | 311 | 0.140 |
Why?
|
| Angiomyoma | 1 | 2016 | 12 | 0.140 |
Why?
|
| Survival Analysis | 14 | 2019 | 10252 | 0.140 |
Why?
|
| Proto-Oncogenes | 2 | 2000 | 321 | 0.140 |
Why?
|
| Polymorphism, Restriction Fragment Length | 9 | 1997 | 769 | 0.140 |
Why?
|
| Microfilament Proteins | 3 | 2003 | 1152 | 0.140 |
Why?
|
| Genes | 2 | 1997 | 1893 | 0.140 |
Why?
|
| Optic Nerve Diseases | 2 | 1997 | 327 | 0.140 |
Why?
|
| Tumor Microenvironment | 3 | 2019 | 3590 | 0.140 |
Why?
|
| Animals | 47 | 2021 | 168768 | 0.130 |
Why?
|
| Osteosarcoma | 2 | 1998 | 881 | 0.130 |
Why?
|
| Oculomotor Nerve | 2 | 1992 | 74 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2010 | 4751 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 2 | 2012 | 1062 | 0.130 |
Why?
|
| DNA Primers | 6 | 2004 | 2891 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2000 | 850 | 0.130 |
Why?
|
| Models, Genetic | 3 | 2006 | 3493 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 582 | 0.130 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2014 | 290 | 0.130 |
Why?
|
| Enzyme Activation | 6 | 2007 | 3702 | 0.130 |
Why?
|
| Cultural Diversity | 1 | 2019 | 359 | 0.130 |
Why?
|
| Adolescent | 36 | 2019 | 85779 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 7 | 2013 | 1142 | 0.130 |
Why?
|
| Axonemal Dyneins | 1 | 2014 | 24 | 0.130 |
Why?
|
| Valine | 2 | 2015 | 413 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 5 | 2014 | 9274 | 0.130 |
Why?
|
| Phosphoproteins | 3 | 2001 | 2441 | 0.130 |
Why?
|
| Choroid Plexus | 2 | 1994 | 231 | 0.130 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2016 | 3480 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 212 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 2 | 1997 | 1364 | 0.130 |
Why?
|
| Genes, APC | 1 | 1995 | 159 | 0.130 |
Why?
|
| Xanthomatosis | 1 | 1994 | 32 | 0.130 |
Why?
|
| Survival Rate | 14 | 2014 | 12788 | 0.120 |
Why?
|
| Oncogenes | 2 | 2018 | 1265 | 0.120 |
Why?
|
| Blotting, Southern | 5 | 2002 | 803 | 0.120 |
Why?
|
| Frozen Sections | 2 | 2015 | 155 | 0.120 |
Why?
|
| JC Virus | 1 | 1994 | 85 | 0.120 |
Why?
|
| Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
| Silver Staining | 3 | 1993 | 64 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 7 | 2011 | 3616 | 0.120 |
Why?
|
| Diffusion of Innovation | 1 | 2019 | 725 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 976 | 0.120 |
Why?
|
| Heterozygote | 11 | 2004 | 2804 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2000 | 1381 | 0.120 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 1995 | 140 | 0.120 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2014 | 177 | 0.120 |
Why?
|
| Brain Diseases | 3 | 2018 | 1563 | 0.120 |
Why?
|
| SEER Program | 2 | 2016 | 1507 | 0.120 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 402 | 0.120 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 449 | 0.120 |
Why?
|
| Cell Division | 8 | 2002 | 4569 | 0.120 |
Why?
|
| Adrenal Cortex | 1 | 2014 | 140 | 0.120 |
Why?
|
| Disease Models, Animal | 12 | 2021 | 18034 | 0.120 |
Why?
|
| Oncolytic Virotherapy | 2 | 2011 | 498 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 338 | 0.120 |
Why?
|
| Olfactory Bulb | 2 | 1992 | 200 | 0.120 |
Why?
|
| Disease-Free Survival | 7 | 2017 | 6896 | 0.110 |
Why?
|
| Education | 1 | 2016 | 543 | 0.110 |
Why?
|
| Genetic Heterogeneity | 5 | 2019 | 733 | 0.110 |
Why?
|
| Microscopy, Electron | 4 | 2004 | 2646 | 0.110 |
Why?
|
| Gene Frequency | 5 | 2011 | 3587 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 874 | 0.110 |
Why?
|
| Antibodies, Viral | 3 | 2020 | 3177 | 0.110 |
Why?
|
| Genetic Engineering | 2 | 2013 | 951 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2009 | 3921 | 0.110 |
Why?
|
| Diplopia | 1 | 2014 | 200 | 0.110 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 12262 | 0.110 |
Why?
|
| Aged, 80 and over | 23 | 2019 | 57776 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2005 | 4222 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2190 | 0.110 |
Why?
|
| Genetic Variation | 4 | 2015 | 6542 | 0.110 |
Why?
|
| Antigens, Neoplasm | 3 | 2021 | 1988 | 0.110 |
Why?
|
| Time Factors | 14 | 2015 | 40075 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2008 | 1771 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 625 | 0.110 |
Why?
|
| Transcription Factors | 7 | 2014 | 12207 | 0.110 |
Why?
|
| Methylation | 2 | 2012 | 1106 | 0.110 |
Why?
|
| Decision Trees | 1 | 2014 | 506 | 0.110 |
Why?
|
| Granuloma | 1 | 1994 | 319 | 0.100 |
Why?
|
| Meningitis, Bacterial | 1 | 1994 | 218 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 1995 | 319 | 0.100 |
Why?
|
| alpha-Crystallin B Chain | 2 | 2008 | 23 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1178 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 1994 | 544 | 0.100 |
Why?
|
| Germ-Line Mutation | 6 | 2017 | 1788 | 0.100 |
Why?
|
| Pedigree | 7 | 2006 | 4642 | 0.100 |
Why?
|
| Stereotaxic Techniques | 3 | 2004 | 536 | 0.100 |
Why?
|
| Caspase 7 | 2 | 2008 | 56 | 0.100 |
Why?
|
| Sequence Deletion | 4 | 2005 | 1525 | 0.100 |
Why?
|
| Nervous System | 1 | 1995 | 554 | 0.100 |
Why?
|
| Necrosis | 4 | 2008 | 1643 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.100 |
Why?
|
| Antineoplastic Agents | 9 | 2012 | 13693 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 1996 | 518 | 0.100 |
Why?
|
| Tissue Embedding | 1 | 2011 | 43 | 0.100 |
Why?
|
| Minority Groups | 1 | 2019 | 1221 | 0.100 |
Why?
|
| Data Display | 1 | 2012 | 182 | 0.100 |
Why?
|
| Cell Differentiation | 14 | 2016 | 11486 | 0.100 |
Why?
|
| Glutamic Acid | 2 | 2015 | 1169 | 0.100 |
Why?
|
| DNA Helicases | 4 | 2015 | 861 | 0.100 |
Why?
|
| Boston | 2 | 2016 | 9312 | 0.100 |
Why?
|
| Anniversaries and Special Events | 1 | 2011 | 89 | 0.100 |
Why?
|
| DNA | 4 | 2006 | 7294 | 0.100 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2005 | 625 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1903 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2011 | 578 | 0.090 |
Why?
|
| Cilia | 1 | 2014 | 466 | 0.090 |
Why?
|
| Pupil | 1 | 1991 | 149 | 0.090 |
Why?
|
| Cyclophosphamide | 4 | 2006 | 2242 | 0.090 |
Why?
|
| Vomiting | 1 | 2014 | 637 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 713 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2000 | 4320 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 5 | 2005 | 1799 | 0.090 |
Why?
|
| Genome, Human | 5 | 2010 | 4420 | 0.090 |
Why?
|
| Carcinoma, Lobular | 1 | 1994 | 484 | 0.090 |
Why?
|
| Sequence Analysis | 2 | 2004 | 256 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 4 | 5 | 2004 | 539 | 0.090 |
Why?
|
| Genotype | 9 | 2012 | 12952 | 0.090 |
Why?
|
| Computer Communication Networks | 1 | 2012 | 295 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 6 | 2018 | 5867 | 0.090 |
Why?
|
| Pneumococcal Infections | 1 | 1994 | 497 | 0.090 |
Why?
|
| Cell Proliferation | 6 | 2018 | 10483 | 0.090 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 399 | 0.090 |
Why?
|
| Lung Neoplasms | 5 | 2013 | 13104 | 0.090 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1991 | 349 | 0.090 |
Why?
|
| Headache | 2 | 2014 | 1226 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14723 | 0.090 |
Why?
|
| Neuroglia | 3 | 2016 | 928 | 0.090 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2010 | 664 | 0.090 |
Why?
|
| Branchioma | 1 | 1989 | 17 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2016 | 3595 | 0.080 |
Why?
|
| Limbic System | 1 | 1992 | 426 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 1998 | 2530 | 0.080 |
Why?
|
| Genomics | 4 | 2016 | 5717 | 0.080 |
Why?
|
| Cysts | 1 | 1994 | 678 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.080 |
Why?
|
| DNA, Complementary | 4 | 2010 | 2050 | 0.080 |
Why?
|
| Anesthetics, Local | 3 | 2005 | 985 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 2839 | 0.080 |
Why?
|
| Neoplasms | 8 | 2015 | 21696 | 0.080 |
Why?
|
| Retrospective Studies | 19 | 2023 | 77460 | 0.080 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 1257 | 0.080 |
Why?
|
| Mosaicism | 1 | 2011 | 441 | 0.080 |
Why?
|
| Child | 23 | 2019 | 77709 | 0.080 |
Why?
|
| Neoplasm Staging | 9 | 2014 | 11031 | 0.080 |
Why?
|
| Retroviridae | 5 | 2003 | 914 | 0.080 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1989 | 101 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2002 | 197 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 944 | 0.080 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 15078 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2012 | 19905 | 0.080 |
Why?
|
| Histology | 1 | 2007 | 16 | 0.080 |
Why?
|
| Mice | 25 | 2021 | 81201 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2005 | 6364 | 0.080 |
Why?
|
| Gene Transfer Techniques | 4 | 2002 | 1225 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2571 | 0.080 |
Why?
|
| Apoptosis | 7 | 2008 | 9724 | 0.080 |
Why?
|
| Thymidine Kinase | 2 | 2000 | 290 | 0.080 |
Why?
|
| Introns | 5 | 2003 | 992 | 0.080 |
Why?
|
| Glycoproteins | 2 | 2006 | 2266 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 2 | 2003 | 743 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2013 | 1077 | 0.080 |
Why?
|
| Ganciclovir | 2 | 2000 | 258 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2006 | 1375 | 0.080 |
Why?
|
| Algorithms | 5 | 2019 | 13882 | 0.080 |
Why?
|
| Microfluidics | 1 | 2013 | 662 | 0.080 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2004 | 356 | 0.080 |
Why?
|
| Amino Acid Sequence | 6 | 2007 | 13814 | 0.080 |
Why?
|
| Synaptophysin | 2 | 2005 | 141 | 0.080 |
Why?
|
| Child, Preschool | 14 | 2019 | 41005 | 0.070 |
Why?
|
| Stem Cells | 4 | 2007 | 3567 | 0.070 |
Why?
|
| Adipokines | 2 | 2006 | 320 | 0.070 |
Why?
|
| Biomedical Engineering | 1 | 2009 | 296 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2725 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 2455 | 0.070 |
Why?
|
| Reference Values | 4 | 1999 | 4982 | 0.070 |
Why?
|
| Cell Separation | 1 | 2013 | 1751 | 0.070 |
Why?
|
| Lectins | 2 | 2006 | 513 | 0.070 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2006 | 152 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 238 | 0.070 |
Why?
|
| Mice, SCID | 5 | 2015 | 2716 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2004 | 1085 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1994 | 1100 | 0.070 |
Why?
|
| Cosmids | 2 | 1997 | 107 | 0.070 |
Why?
|
| RNA Interference | 3 | 2013 | 2890 | 0.070 |
Why?
|
| Biotechnology | 1 | 2008 | 281 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 2 | 2002 | 1081 | 0.070 |
Why?
|
| Microscopy | 1 | 2012 | 902 | 0.070 |
Why?
|
| Sciatic Nerve | 4 | 2005 | 607 | 0.070 |
Why?
|
| Biometry | 1 | 2009 | 558 | 0.070 |
Why?
|
| Ligases | 2 | 1998 | 333 | 0.070 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 39052 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2011 | 732 | 0.070 |
Why?
|
| Neuroblastoma | 2 | 1992 | 1226 | 0.070 |
Why?
|
| In Situ Hybridization | 4 | 2005 | 1950 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2009 | 530 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2011 | 1728 | 0.070 |
Why?
|
| Paxillin | 1 | 2005 | 86 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2008 | 758 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 2638 | 0.070 |
Why?
|
| Microsatellite Instability | 1 | 2009 | 684 | 0.070 |
Why?
|
| Antibody Specificity | 2 | 2020 | 1095 | 0.070 |
Why?
|
| Microdissection | 1 | 2005 | 152 | 0.070 |
Why?
|
| Integrin beta Chains | 1 | 2005 | 121 | 0.070 |
Why?
|
| Gene Expression | 8 | 2014 | 7798 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 1222 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2014 | 323 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2008 | 690 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 2005 | 709 | 0.060 |
Why?
|
| Amino Acid Substitution | 4 | 2014 | 1793 | 0.060 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2005 | 135 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 376 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1990 | 501 | 0.060 |
Why?
|
| Leiomyosarcoma | 1 | 1989 | 477 | 0.060 |
Why?
|
| Lymphoma | 4 | 2004 | 1877 | 0.060 |
Why?
|
| Sample Size | 2 | 2005 | 845 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 2 | 2002 | 183 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5388 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1058 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2001 | 2327 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2016 | 3743 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1996 | 1596 | 0.060 |
Why?
|
| DNA Mismatch Repair | 1 | 2008 | 426 | 0.060 |
Why?
|
| Cyclin D1 | 2 | 2004 | 463 | 0.060 |
Why?
|
| Syndrome | 3 | 1995 | 3252 | 0.060 |
Why?
|
| Recurrence | 2 | 2012 | 8340 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1202 | 0.060 |
Why?
|
| Receptors, Virus | 2 | 2004 | 649 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 300 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 480 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.060 |
Why?
|
| Breast Neoplasms | 4 | 2013 | 20824 | 0.060 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 337 | 0.060 |
Why?
|
| Neoplasms, Experimental | 3 | 2004 | 1276 | 0.060 |
Why?
|
| Peripheral Nerves | 2 | 2002 | 466 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2005 | 434 | 0.060 |
Why?
|
| Genes, erbB-2 | 1 | 2004 | 162 | 0.060 |
Why?
|
| Gene Library | 2 | 1997 | 1074 | 0.060 |
Why?
|
| Equipment Design | 1 | 2012 | 3582 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2003 | 119 | 0.060 |
Why?
|
| Callithrix | 1 | 2003 | 93 | 0.060 |
Why?
|
| Hemangioma, Cavernous | 2 | 1995 | 110 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2004 | 3759 | 0.060 |
Why?
|
| Exercise Test | 1 | 2011 | 2073 | 0.060 |
Why?
|
| Codon | 3 | 1995 | 611 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10183 | 0.060 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2003 | 60 | 0.060 |
Why?
|
| CDC2 Protein Kinase | 1 | 2004 | 220 | 0.060 |
Why?
|
| Tuberous Sclerosis | 2 | 2001 | 1029 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2016 | 20130 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2007 | 694 | 0.050 |
Why?
|
| Cell Survival | 2 | 2011 | 5882 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2004 | 1101 | 0.050 |
Why?
|
| Young Adult | 11 | 2019 | 56429 | 0.050 |
Why?
|
| Isochromosomes | 1 | 2002 | 16 | 0.050 |
Why?
|
| Carcinoma | 2 | 2013 | 2375 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2006 | 772 | 0.050 |
Why?
|
| Vindesine | 1 | 2002 | 12 | 0.050 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2004 | 191 | 0.050 |
Why?
|
| Cell Cycle | 4 | 2003 | 2967 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2002 | 90 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2003 | 259 | 0.050 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2002 | 60 | 0.050 |
Why?
|
| Brain Edema | 1 | 2007 | 617 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2004 | 698 | 0.050 |
Why?
|
| Phospholipases A2 | 1 | 2002 | 203 | 0.050 |
Why?
|
| Software | 1 | 2016 | 4441 | 0.050 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2002 | 125 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2003 | 968 | 0.050 |
Why?
|
| Hamartoma | 2 | 2001 | 238 | 0.050 |
Why?
|
| DNA Damage | 1 | 2011 | 2432 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 96 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2373 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 1284 | 0.050 |
Why?
|
| Medical Oncology | 2 | 2017 | 2267 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2011 | 1972 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 2004 | 1101 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 1534 | 0.050 |
Why?
|
| Adiposis Dolorosa | 1 | 2001 | 12 | 0.050 |
Why?
|
| Y Chromosome | 1 | 2002 | 206 | 0.050 |
Why?
|
| International Agencies | 2 | 2012 | 240 | 0.050 |
Why?
|
| Rats | 11 | 2006 | 24252 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1438 | 0.050 |
Why?
|
| Phylogeny | 2 | 2016 | 2804 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2000 | 1378 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2005 | 12356 | 0.050 |
Why?
|
| Radial Nerve | 1 | 2000 | 43 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2009 | 1401 | 0.050 |
Why?
|
| Olfactory Pathways | 2 | 1992 | 121 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2001 | 269 | 0.050 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2002 | 122 | 0.050 |
Why?
|
| Spinal Nerves | 1 | 2000 | 86 | 0.050 |
Why?
|
| Sports | 1 | 1986 | 688 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2006 | 1005 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 1991 | 2647 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2001 | 180 | 0.040 |
Why?
|
| Glia Maturation Factor | 1 | 1999 | 15 | 0.040 |
Why?
|
| Neurology | 2 | 2017 | 763 | 0.040 |
Why?
|
| Ligands | 2 | 2005 | 3282 | 0.040 |
Why?
|
| Complement System Proteins | 2 | 2000 | 795 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2825 | 0.040 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2715 | 0.040 |
Why?
|
| Thyroid Neoplasms | 2 | 2013 | 2282 | 0.040 |
Why?
|
| Nerve Block | 2 | 2003 | 644 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7282 | 0.040 |
Why?
|
| Cohort Studies | 7 | 2019 | 40559 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2005 | 1355 | 0.040 |
Why?
|
| Neoplasm Transplantation | 4 | 2008 | 2086 | 0.040 |
Why?
|
| Thoracic Neoplasms | 1 | 2002 | 268 | 0.040 |
Why?
|
| Telomere | 2 | 1995 | 910 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10943 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 402 | 0.040 |
Why?
|
| Radiosurgery | 1 | 2009 | 1329 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2000 | 381 | 0.040 |
Why?
|
| Treatment Outcome | 12 | 2015 | 63107 | 0.040 |
Why?
|
| Epigenomics | 2 | 2015 | 903 | 0.040 |
Why?
|
| Cell Cycle Proteins | 3 | 2011 | 3464 | 0.040 |
Why?
|
| Gadolinium | 1 | 2004 | 952 | 0.040 |
Why?
|
| Neurons | 3 | 2007 | 9340 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2015 | 5534 | 0.040 |
Why?
|
| Vimentin | 2 | 2005 | 262 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 2020 | 1537 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2019 | 5791 | 0.040 |
Why?
|
| Bupivacaine | 1 | 2002 | 411 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 15520 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 1998 | 1862 | 0.040 |
Why?
|
| Sarcoma | 1 | 1990 | 1897 | 0.040 |
Why?
|
| Virus Replication | 4 | 2011 | 2535 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2006 | 5223 | 0.040 |
Why?
|
| Infant | 7 | 2019 | 35134 | 0.040 |
Why?
|
| Models, Biological | 3 | 2018 | 9584 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5321 | 0.040 |
Why?
|
| Radiotherapy | 3 | 2011 | 1533 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2021 | 350 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Adenoma, Islet Cell | 1 | 1997 | 82 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3873 | 0.040 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 2 | 1995 | 105 | 0.040 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2018 | 72 | 0.040 |
Why?
|
| Cytoplasm | 2 | 1994 | 1536 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2005 | 7721 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1041 | 0.040 |
Why?
|
| Age Distribution | 1 | 2004 | 2902 | 0.040 |
Why?
|
| Dependovirus | 1 | 2002 | 706 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2018 | 8436 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 589 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2011 | 3689 | 0.040 |
Why?
|
| Peptide Initiation Factors | 1 | 1997 | 56 | 0.040 |
Why?
|
| Mitochondria | 2 | 2008 | 3514 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 2418 | 0.040 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2001 | 484 | 0.040 |
Why?
|
| Titrimetry | 1 | 1996 | 36 | 0.040 |
Why?
|
| Giant Cells | 1 | 1997 | 187 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 752 | 0.040 |
Why?
|
| Mice, Transgenic | 5 | 2013 | 9735 | 0.040 |
Why?
|
| Cell Line | 5 | 2008 | 16000 | 0.040 |
Why?
|
| Injections | 1 | 2000 | 840 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 3848 | 0.040 |
Why?
|
| Demyelinating Diseases | 2 | 1998 | 354 | 0.040 |
Why?
|
| Haplotypes | 1 | 2003 | 2779 | 0.040 |
Why?
|
| Microtubules | 2 | 1994 | 1089 | 0.040 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1996 | 45 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15535 | 0.040 |
Why?
|
| Molecular Probes | 2 | 1995 | 316 | 0.040 |
Why?
|
| Immunity, Innate | 2 | 2006 | 2962 | 0.030 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3505 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1997 | 374 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1996 | 122 | 0.030 |
Why?
|
| Gliosarcoma | 1 | 1996 | 114 | 0.030 |
Why?
|
| Blood Proteins | 2 | 1997 | 1124 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2018 | 371 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2000 | 2987 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2000 | 799 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1995 | 69 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7182 | 0.030 |
Why?
|
| Cisplatin | 1 | 2002 | 1662 | 0.030 |
Why?
|
| Lymphoma, T-Cell | 1 | 1998 | 299 | 0.030 |
Why?
|
| Viruses | 1 | 1999 | 375 | 0.030 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6366 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1581 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2002 | 2008 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2011 | 6539 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 1239 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 1995 | 137 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1996 | 234 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1996 | 295 | 0.030 |
Why?
|
| Neurofibromin 1 | 1 | 1996 | 196 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5511 | 0.030 |
Why?
|
| Karnofsky Performance Status | 2 | 2008 | 173 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2006 | 6194 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1999 | 839 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2009 | 5101 | 0.030 |
Why?
|
| Disease Management | 2 | 2015 | 2460 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1879 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2004 | 2417 | 0.030 |
Why?
|
| Colloids | 1 | 1994 | 136 | 0.030 |
Why?
|
| Centromere | 1 | 1995 | 220 | 0.030 |
Why?
|
| Fibronectins | 1 | 1998 | 726 | 0.030 |
Why?
|
| Digoxin | 1 | 2015 | 250 | 0.030 |
Why?
|
| Central Nervous System Cysts | 1 | 2014 | 58 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 520 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2020 | 6459 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 903 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 1999 | 2421 | 0.030 |
Why?
|
| Oximes | 1 | 2015 | 311 | 0.030 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 1993 | 43 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 1993 | 285 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 940 | 0.030 |
Why?
|
| Dinucleoside Phosphates | 1 | 1994 | 74 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2000 | 2618 | 0.030 |
Why?
|
| Bayes Theorem | 2 | 2014 | 2307 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2021 | 25628 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1999 | 1125 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2006 | 17446 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 284 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 1994 | 2969 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 64 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2014 | 194 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 1736 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 4561 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2002 | 4851 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2015 | 370 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1995 | 241 | 0.030 |
Why?
|
| Virion | 2 | 2006 | 433 | 0.030 |
Why?
|
| Karyotyping | 1 | 1995 | 1243 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2014 | 841 | 0.030 |
Why?
|
| Rats, Inbred F344 | 3 | 1999 | 862 | 0.030 |
Why?
|
| Parathyroid Neoplasms | 1 | 1994 | 245 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 675 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Blood Volume | 1 | 1994 | 565 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1995 | 880 | 0.030 |
Why?
|
| Cytidine | 1 | 1992 | 68 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2124 | 0.030 |
Why?
|
| Fetus | 2 | 2001 | 1880 | 0.030 |
Why?
|
| Cell Movement | 1 | 2004 | 5218 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2007 | 1701 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 1707 | 0.030 |
Why?
|
| S100 Proteins | 1 | 1992 | 259 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2010 | 1783 | 0.030 |
Why?
|
| Seizures | 1 | 2004 | 2859 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2133 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 375 | 0.030 |
Why?
|
| Injections, Intralesional | 2 | 2004 | 276 | 0.030 |
Why?
|
| Eye Neoplasms | 1 | 1993 | 312 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2004 | 1813 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2004 | 3444 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1995 | 524 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 847 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 1992 | 109 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 500 | 0.020 |
Why?
|
| Neurofibrils | 1 | 1991 | 76 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 3771 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2014 | 19233 | 0.020 |
Why?
|
| Cell Size | 1 | 2013 | 643 | 0.020 |
Why?
|
| United States | 6 | 2019 | 69872 | 0.020 |
Why?
|
| Pyridones | 1 | 2015 | 711 | 0.020 |
Why?
|
| Vero Cells | 1 | 2011 | 485 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 21833 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2015 | 973 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1994 | 667 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 1994 | 600 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 767 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
| Phenotype | 3 | 2019 | 16367 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1998 | 1741 | 0.020 |
Why?
|
| Cervical Vertebrae | 2 | 1994 | 976 | 0.020 |
Why?
|
| Arachnoid | 1 | 2010 | 48 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1993 | 554 | 0.020 |
Why?
|
| Rats, Nude | 2 | 2000 | 105 | 0.020 |
Why?
|
| Transgenes | 2 | 2004 | 1009 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 769 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 1997 | 1023 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 4933 | 0.020 |
Why?
|
| Microspheres | 2 | 2003 | 777 | 0.020 |
Why?
|
| Massachusetts | 2 | 2020 | 8662 | 0.020 |
Why?
|
| Smell | 1 | 1992 | 244 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 2 | 1997 | 5263 | 0.020 |
Why?
|
| RNA | 1 | 2000 | 2749 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 3617 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 851 | 0.020 |
Why?
|
| Transfection | 3 | 2005 | 5895 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1992 | 572 | 0.020 |
Why?
|
| Protein Kinases | 2 | 2007 | 1640 | 0.020 |
Why?
|
| Imidazoles | 1 | 2015 | 1206 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2007 | 2088 | 0.020 |
Why?
|
| Flow Cytometry | 3 | 2007 | 5974 | 0.020 |
Why?
|
| Microglia | 1 | 2017 | 1267 | 0.020 |
Why?
|
| Thiotepa | 1 | 2008 | 66 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1620 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2002 | 9955 | 0.020 |
Why?
|
| Transduction, Genetic | 2 | 2003 | 913 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 1059 | 0.020 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 155 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 1683 | 0.020 |
Why?
|
| RNA Splicing | 3 | 1999 | 908 | 0.020 |
Why?
|
| Sacrum | 1 | 1990 | 288 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 328 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1990 | 610 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2008 | 242 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 1986 | 5035 | 0.020 |
Why?
|
| Research | 1 | 2016 | 1999 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2002 | 442 | 0.020 |
Why?
|
| Apoptosomes | 1 | 2007 | 4 | 0.020 |
Why?
|
| Busulfan | 1 | 2008 | 263 | 0.020 |
Why?
|
| DNA Probes | 3 | 1993 | 560 | 0.020 |
Why?
|
| Adenine | 1 | 1992 | 936 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 385 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1656 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12244 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1996 | 1856 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2007 | 188 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 322 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 180 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1692 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 551 | 0.020 |
Why?
|
| Hypesthesia | 1 | 2006 | 109 | 0.020 |
Why?
|
| Frameshift Mutation | 2 | 2000 | 399 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1677 | 0.020 |
Why?
|
| Tissue Donors | 1 | 1995 | 2241 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1990 | 547 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1996 | 2916 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 2879 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2013 | 990 | 0.020 |
Why?
|
| Adenovirus E1B Proteins | 1 | 2004 | 15 | 0.020 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 422 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 137 | 0.020 |
Why?
|
| Organ Transplantation | 1 | 1995 | 1140 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 733 | 0.020 |
Why?
|
| Paraganglioma | 1 | 2006 | 143 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1993 | 4010 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 880 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 738 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2007 | 465 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2015 | 4026 | 0.020 |
Why?
|
| Carmustine | 1 | 2004 | 137 | 0.020 |
Why?
|
| Phagocytes | 1 | 2006 | 297 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 1254 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3799 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2005 | 199 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3511 | 0.010 |
Why?
|
| Ectoderm | 1 | 2004 | 137 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 894 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1998 | 3079 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3476 | 0.010 |
Why?
|
| Acute Disease | 1 | 1994 | 7147 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 457 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1990 | 1072 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3611 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2383 | 0.010 |
Why?
|
| Syndecans | 1 | 2003 | 79 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3531 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1990 | 760 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 318 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 2003 | 570 | 0.010 |
Why?
|
| Incidence | 3 | 2016 | 20952 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 8300 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 1549 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2003 | 193 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 2004 | 348 | 0.010 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2002 | 43 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2003 | 245 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2006 | 1005 | 0.010 |
Why?
|
| DNA Repair | 1 | 2011 | 2046 | 0.010 |
Why?
|
| Syndecan-1 | 1 | 2003 | 165 | 0.010 |
Why?
|
| Macrophages | 1 | 2017 | 5660 | 0.010 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2003 | 281 | 0.010 |
Why?
|
| Lactose | 1 | 2002 | 95 | 0.010 |
Why?
|
| Philosophy | 1 | 2002 | 66 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 906 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2002 | 192 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1989 | 1173 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 2 | 2005 | 2727 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 156 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1994 | 355 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1101 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1483 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2004 | 323 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2933 | 0.010 |
Why?
|
| Capillaries | 1 | 2004 | 773 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 1157 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2003 | 270 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2002 | 588 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7730 | 0.010 |
Why?
|
| Selection Bias | 1 | 2003 | 371 | 0.010 |
Why?
|
| Choline | 1 | 2002 | 493 | 0.010 |
Why?
|
| Hand | 1 | 2006 | 884 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2007 | 878 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3646 | 0.010 |
Why?
|
| Laminectomy | 1 | 2002 | 234 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1856 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2006 | 740 | 0.010 |
Why?
|
| Muscles | 1 | 2005 | 1614 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2000 | 40 | 0.010 |
Why?
|
| Inflammation | 2 | 2002 | 10637 | 0.010 |
Why?
|
| Autoantigens | 1 | 2005 | 892 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2000 | 142 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8091 | 0.010 |
Why?
|
| Viscera | 1 | 2001 | 139 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 2000 | 141 | 0.010 |
Why?
|
| Polyglycolic Acid | 1 | 2002 | 407 | 0.010 |
Why?
|
| Cyclin D3 | 1 | 2000 | 55 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 7023 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 2000 | 79 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2001 | 251 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2000 | 54 | 0.010 |
Why?
|
| Rabbits | 1 | 2007 | 4894 | 0.010 |
Why?
|
| Neprilysin | 1 | 2003 | 439 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 1641 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2000 | 5077 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 2000 | 190 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2001 | 6621 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2000 | 277 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1999 | 6773 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 837 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 12073 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 2000 | 192 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 255 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 1999 | 122 | 0.010 |
Why?
|
| Brain Abscess | 1 | 2000 | 118 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2917 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 562 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 853 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 1794 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 2004 | 636 | 0.010 |
Why?
|
| Growth Substances | 1 | 2001 | 784 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 675 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1547 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 1828 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1990 | 2029 | 0.010 |
Why?
|
| Chromosomes | 1 | 2001 | 596 | 0.010 |
Why?
|
| Virus Activation | 1 | 2000 | 319 | 0.010 |
Why?
|
| Gastrinoma | 1 | 1997 | 21 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2000 | 475 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 3207 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2308 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1281 | 0.010 |
Why?
|
| Clone Cells | 1 | 2001 | 1692 | 0.010 |
Why?
|
| Periodicity | 1 | 1999 | 364 | 0.010 |
Why?
|
| Data Collection | 1 | 2007 | 3339 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1998 | 216 | 0.010 |
Why?
|
| Inositol | 1 | 1998 | 218 | 0.010 |
Why?
|
| Actins | 1 | 2005 | 2121 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1997 | 441 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2700 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 2002 | 608 | 0.010 |
Why?
|
| Insulinoma | 1 | 1997 | 124 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1892 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 898 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2002 | 594 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 2000 | 470 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 1132 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2008 | 2943 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4839 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 1997 | 107 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 1996 | 45 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1782 | 0.010 |
Why?
|
| Methotrexate | 1 | 2003 | 1728 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 1608 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 2736 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2726 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 1995 | 79 | 0.010 |
Why?
|
| Lymphoma, Large-Cell, Immunoblastic | 1 | 1994 | 26 | 0.010 |
Why?
|
| Lod Score | 1 | 1995 | 614 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1998 | 1865 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1996 | 718 | 0.010 |
Why?
|
| Polymers | 1 | 2002 | 1621 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 1402 | 0.010 |
Why?
|
| Remission Induction | 1 | 2000 | 2385 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 3270 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1991 | 5709 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 5451 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 4034 | 0.010 |
Why?
|
| Encephalitis | 1 | 1998 | 425 | 0.010 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 1994 | 84 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3486 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2000 | 1275 | 0.010 |
Why?
|
| Immunization | 1 | 1998 | 1256 | 0.010 |
Why?
|
| Ploidies | 1 | 1993 | 281 | 0.010 |
Why?
|
| Italy | 1 | 1995 | 832 | 0.010 |
Why?
|
| Cricetinae | 1 | 1997 | 2475 | 0.010 |
Why?
|
| Cerebellum | 1 | 2000 | 1488 | 0.010 |
Why?
|
| Silver | 1 | 1993 | 122 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 1127 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 170 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2004 | 1832 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4162 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6386 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2003 | 2616 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2000 | 2617 | 0.010 |
Why?
|
| Reoperation | 1 | 2002 | 4201 | 0.010 |
Why?
|
| Autoradiography | 1 | 1993 | 745 | 0.010 |
Why?
|
| Amino Acids | 1 | 1998 | 1737 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2004 | 53290 | 0.010 |
Why?
|
| Colon | 1 | 1999 | 1772 | 0.010 |
Why?
|
| Proteomics | 1 | 2004 | 3638 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1801 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 8319 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1213 | 0.010 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 5692 | 0.010 |
Why?
|
| Age Factors | 2 | 2001 | 18373 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13409 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2219 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 1991 | 8038 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 1994 | 659 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1998 | 1889 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1994 | 847 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1992 | 931 | 0.010 |
Why?
|
| Risk Factors | 2 | 2011 | 72296 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1992 | 913 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1994 | 1117 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1999 | 3037 | 0.000 |
Why?
|
| Kidney | 1 | 2003 | 7184 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3690 | 0.000 |
Why?
|
| Liver | 1 | 2003 | 7475 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4153 | 0.000 |
Why?
|
| Hypertension | 1 | 2006 | 8479 | 0.000 |
Why?
|
| Pain | 1 | 2001 | 4988 | 0.000 |
Why?
|
| Protein Binding | 1 | 1998 | 9384 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2005 | 23336 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1994 | 2732 | 0.000 |
Why?
|
| Adenoma | 1 | 1994 | 2174 | 0.000 |
Why?
|
| Aging | 1 | 2002 | 8664 | 0.000 |
Why?
|
| Pregnancy | 1 | 2001 | 29144 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 25039 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15297 | 0.000 |
Why?
|